Skip to main content
Season 3 ends in 25 d 11:42:40 $2,000 10,000 pts = 1 month Premium
Health & Medicine

Global Tuberculosis Report 2026: Key Numbers Explained

Published 12 min read
Open the post and read it to claim 30 points
A gloved hand holding a sputum sample cup above a molecular TB test machine in a hospital lab, illustrating the Global Tuberculosis Report 2026

Sign in and earn +30 points by reading this

Read to the end, wait a few seconds, then tap the claim button below.

In short

WHO's Global Tuberculosis Report 2026, released on 12 November 2026, estimates that 10.6 million people fell ill with TB in 2025 and 1.13 million died [1][2]. TB deaths have fallen 35% since 2015, but about 2.2 million cases went undiagnosed or unreported and only 42% of people with drug-resistant TB were treated [1].

Key takeaways

  1. The report, published on 12 November 2026, uses data from 187 countries and areas with more than 99% of the world's population and TB cases [1][3].
  2. In 2025, about 10.6 million people developed TB and 1.13 million died, including 137,000 people with HIV [2][4].
  3. Deaths are down 35% since 2015, reaching the first End TB Strategy milestone five years late; incidence fell only 14%, against a 50% milestone [1].
  4. Of 10.6 million cases, 8.4 million were diagnosed; just 59% of newly diagnosed people got a WHO-recommended rapid test [1].
  5. Only 42% of the estimated 370,000 people with rifampicin-resistant TB received treatment in 2025 [1].
  6. Domestic TB funding rose 14% to US$5.6 billion, while international donor funding fell 14% to US$0.94 billion [1][4].
  7. This is not medical advice: people with a long cough, fever or weight loss should see a health worker.
On this page 12 sections
  1. What does the Global Tuberculosis Report 2026 say?
  2. How many people die from tuberculosis each year?
  3. Which countries have the most TB cases?
  4. How many TB cases go undiagnosed?
  5. What is drug-resistant TB and is it treatable?
  6. What are the symptoms of tuberculosis?
  7. How is TB funded and what has changed?
  8. Is there a new tuberculosis vaccine?
  9. Common mistakes
  10. Frequently asked questions
  11. Glossary
  12. Sources

What does the Global Tuberculosis Report 2026 say?

The report says TB is still falling, but too slowly: 10.6 million people fell ill and 1.13 million died in 2025, and TB remains the world's leading cause of death from a single infectious agent [1][2]. WHO released it on 12 November 2026 [1].

The headline progress is on deaths. They have fallen 35% since 2015, which means the world reached the first mortality milestone of WHO's End TB Strategy, although five years later than planned [1]. WHO estimates that TB treatment has saved about 86 million lives since 2000 [1].

The weak point is new cases. The global incidence rate, meaning new cases per 100,000 people, has dropped by only 14% since 2015, far short of the 50% reduction set as the milestone for 2025 [1]. WHO Director-General Tedros Adhanom Ghebreyesus called the continued decline "very encouraging" but said more than one million people still die each year from a disease that is preventable and treatable [1].

WHO warns that its burden estimates should be read using the latest time series, because direct comparisons with numbers in earlier editions are not appropriate [2].

How many people die from tuberculosis each year?

WHO estimates that 1.13 million people died of TB in 2025, including 137,000 people with HIV [2][4]. The WHO news release rounds the figure to 1.1 million [1].

The 10.6 million people who fell ill in 2025 included 5.7 million men, 3.7 million women and 1.2 million children [4]. TB was also the leading killer of people with HIV and a major cause of deaths linked to antimicrobial resistance [4]. People living with HIV are 12 times more likely to fall ill with TB, and only 59% of people with HIV who developed TB received antiretroviral therapy in 2025 [4].

About a quarter of the world's population is estimated to have been infected with TB bacteria, but most never become ill: WHO says about 5 to 10% of infected people eventually develop TB disease [4]. People with TB infection generally do not feel sick and are not contagious [4].

Slender curved rod-shaped bacteria in a translucent lung air-sac space with capillaries, showing the cause of TB in the Global Tuberculosis Report 2026
TB is caused by bacteria that most often affect the lungs and spread through the air.

Which countries have the most TB cases?

Thirty high-burden countries accounted for 88% of people who developed TB in 2025, and about a quarter of all cases were in India [1][4]. WHO's fact sheet lists the largest shares as India (about a quarter), Indonesia (10%), the Philippines (6.8%), China (6.5%), Pakistan (6.4%), Nigeria (4.9%), the Democratic Republic of the Congo (3.9%) and Bangladesh (3.7%); the top five countries made up 55% of the total [4].

By WHO region, the South-East Asia Region had 35% of new cases, the Western Pacific 27% and the African Region 25% [4].

Progress since 2015 has been very uneven [1]:

  • European Region: incidence down 42%.
  • African Region: down 30%.
  • South-East Asia: down 18%.
  • Eastern Mediterranean: down only 6.6%.
  • Western Pacific: no net change.
  • Americas: up for the fifth year in a row, 13% above 2015.

WHO links these differences to TB risk factors, the strength of health systems, access to services and sustained investment [1].

A night globe of South and South-East Asia with glowing gold points, brightest over India, plus the Indonesian and Philippine islands, matching the caption on TB case shares in 2025
India, Indonesia and the Philippines had the largest shares of TB cases in 2025.

How many TB cases go undiagnosed?

Of the estimated 10.6 million people who developed TB in 2025, 8.4 million were diagnosed, leaving about 2.2 million undiagnosed or unreported [1]. Missed cases matter because WHO says TB symptoms may be mild for many months, so people can spread the disease without knowing it [4].

Testing quality is also a gap. Only 59% of newly diagnosed patients were tested with a WHO-recommended rapid diagnostic test, against a target of 100% by 2027 [1]. WHO recommends rapid tests, including molecular assays and biomarker-based point-of-care tests, as the first test for everyone with signs and symptoms; they can give initial results within 48 hours of sample collection [4].

For finding infection rather than disease, WHO lists the tuberculin skin test, the interferon gamma release assay (IGRA) blood test and newer antigen-based skin tests [4]. These identify people at high risk who may benefit from TB preventive treatment [4]. Software that reads chest X-rays and other AI tools in medicine raise their own questions of accuracy and regulation, covered in the Pouyam guide AI in Healthcare: What It Can Do Today, Where It Fails and How It Is Regulated.

What is drug-resistant TB and is it treatable?

Drug-resistant TB does not respond to the standard medicines, but WHO says multidrug-resistant TB is treatable and curable with other drugs; the problem is access, since only 42% of the estimated 370,000 people with rifampicin-resistant TB were treated in 2025 [1][4].

Multidrug-resistant TB (MDR-TB) is caused by bacteria that do not respond to rifampicin and isoniazid, the two most effective first-line drugs [4]. Resistance emerges when medicines are used inappropriately: wrong prescriptions, poor-quality drugs or patients stopping treatment early [4]. Extensively drug-resistant TB (XDR-TB) leaves very limited treatment options [4].

There is one clear improvement. The share of treated people receiving WHO-recommended six-month regimens rose from 18% in 2024 to 42% in 2025, and these regimens were in use in 106 countries by the end of 2025 [1][4]. WHO first prioritised a short six-month all-oral regimen in 2022 [4].

Shelves of white blister packs, a five-compartment pill organiser and a glass of water, a generic pharmacy scene accompanying the tuberculosis treatment section
Six-month regimens were used for 42% of people treated for drug-resistant TB in 2025.

What are the symptoms of tuberculosis?

WHO lists the common symptoms as a prolonged cough (sometimes with blood), chest pain, weakness, fatigue, weight loss, fever and night sweats [4]. TB usually affects the lungs but can also involve the kidneys, brain, spine and skin, and the symptoms depend on which part of the body is affected [4]. Some people with TB disease have no symptoms but can still spread it [4].

TB spreads through the air when people with TB cough, sneeze or spit [4]. People with weakened immune systems, including people with HIV, undernutrition or diabetes, and people who use tobacco face a higher risk of falling ill [4]. WHO estimates that in 2025 about 0.96 million new cases were attributable to undernutrition, 0.92 million to diabetes, 0.73 million to alcohol use disorders, 0.69 million to smoking and 0.55 million to HIV [4].

WHO advises seeking medical attention for symptoms such as a prolonged cough, fever and unexplained weight loss, and getting screened if at higher risk, for example with HIV or a household contact with TB [4]. Treatment uses special antibiotics taken daily for 4 to 6 months, and WHO warns that stopping early without medical advice can make the bacteria resistant [4].

This is not medical advice. Diagnosis and treatment decisions belong with a health worker or national TB programme.

How is TB funded and what has changed?

Domestic funding for TB rose 14% to US$5.6 billion between 2024 and 2025, partly offsetting a fall in international money: donor funding dropped 14%, from US$1.1 billion to US$0.94 billion [1][4]. Most TB spending in 2025, 86%, came from domestic sources, and Brazil, China, India, the Russian Federation and South Africa provided US$3.7 billion of the US$5.63 billion from domestic sources in low- and middle-income countries [4].

The needs are much larger. WHO says US$22 billion a year is needed by 2027 for prevention, diagnosis, treatment and care to reach the targets agreed at the 2023 UN high-level meeting on TB [4]. Research funding was US$1.2 billion in 2023, less than a quarter of the US$5 billion annual target for 2027 [1].

The cost to families is heavy too: about half of people treated for TB and their households face total costs above 20% of household income, which WHO calls catastrophic, against an End TB Strategy target of zero [4].

Is there a new tuberculosis vaccine?

Not yet: the TB vaccine in use is BCG, given to babies or young children in some countries, while new candidates are still in trials [4][5]. WHO says BCG prevents deaths from TB and protects children from serious forms of the disease [4]. According to the Royal Society of Tropical Medicine and Hygiene's summary of the report, 12 vaccine candidates are in clinical development and three of them are in Phase 3 trials [5].

WHO's call to governments is to strengthen political commitment, protect and increase financing, expand prevention, rapid diagnosis and effective treatment, and invest in new tools [1]. As of 13 November 2026, WHO's verdict is that progress must be much faster to get back on track [1].

Health statistics like these are often repeated with errors online and by chatbots; the Pouyam guide AI Hallucinations Explained: Why Chatbots Make Things Up and How to Get Accurate Answers explains why AI answers can invent or mix up figures and how to check them against the original report.

WHO Global Tuberculosis Report 2026: headline figures for 2025 (released 12 November 2026)
MeasureFigure
People who developed TB10.6 million
Deaths from TB1.13 million (including 137,000 among people with HIV)
Change in deaths since 2015down 35%
Change in incidence rate since 2015down 14% (milestone was 50%)
People diagnosed8.4 million (about 2.2 million undiagnosed or unreported)
Newly diagnosed tested with a rapid test59%
Rifampicin-resistant TB cases treated42% of an estimated 370,000
Domestic TB fundingUS$5.6 billion, up 14%
International donor fundingUS$0.94 billion, down 14%
Lives saved since 2000about 86 million

Common mistakes

  • Comparing 2026 report estimates with numbers from older editions.

    Fix: WHO says direct comparisons with earlier editions are not appropriate; use the latest time series [2].

  • Assuming TB infection always means illness.

    Fix: Only about 5 to 10% of infected people develop TB disease, and people with infection are generally not contagious [4].

  • Stopping TB medicine when you feel better.

    Fix: WHO warns that stopping early without medical advice can make the bacteria drug-resistant [4].

  • Reading the 35% fall in deaths as the epidemic ending.

    Fix: Incidence fell only 14% since 2015, far short of the 50% milestone [1].

Frequently asked questions

What does the Global Tuberculosis Report 2026 say?

In 2025, 10.6 million people fell ill with TB and 1.13 million died; deaths are down 35% since 2015 but incidence only 14% [1][2].

How many people die from tuberculosis each year?

About 1.13 million in 2025, including 137,000 people with HIV [2][4].

Which countries have the most TB cases?

India had about a quarter of cases, followed by Indonesia, the Philippines, China and Pakistan; 30 countries had 88% [4].

What are the symptoms of tuberculosis?

A prolonged cough, sometimes with blood, chest pain, weakness, fatigue, weight loss, fever and night sweats, WHO says [4].

Is tuberculosis curable?

WHO says TB disease is treated with antibiotics taken daily for 4 to 6 months, and MDR-TB is treatable and curable with other drugs [4].

Is there a new tuberculosis vaccine?

BCG is the vaccine in use; 12 candidates are in clinical development, three in Phase 3, per the RSTMH summary [4][5].

Glossary

Incidence rate
New TB cases per 100,000 people in a year [1].
End TB Strategy
WHO's strategy with milestones for cutting TB deaths and new cases [1].
Rifampicin-resistant TB
TB that does not respond to rifampicin, a key first-line drug [1][4].
MDR-TB
TB resistant to both rifampicin and isoniazid [4].
TB preventive treatment
Medicine that stops TB infection from becoming disease [4].
BCG
Bacille Calmette-Guerin, the TB vaccine given to babies or young children in some countries [4].

Sources

  1. Amid challenges, countries increase domestic investment to protect progress against tuberculosis World Health Organization · 2026-11-12
  2. Global tuberculosis report 2026 World Health Organization · 2026-11-12
  3. Global tuberculosis report 2026 World Health Organization · 2026-11-12
  4. Tuberculosis: fact sheet World Health Organization · 2026-11-12
  5. WHO Global TB Report 2026: TB deaths down 35%, but funding gaps threaten progress Royal Society of Tropical Medicine and Hygiene
Share this guide Telegram WhatsApp X
0 likes

Comments

Top comments

About the Pouyam Team Editorial policy

On Pouyam

Explore Pouyam

Guides are one corner of Pouyam. Here is where to go next.

Quick navigation